SelectQuote, Inc.

SelectQuote, Inc. (SLQT) Market Cap

SelectQuote, Inc. has a market capitalization of $146.3M.

Financials based on reported quarter end 2025-12-31

Price: $0.83

0.06 (8.41%)

Market Cap: 146.32M

NYSE · time unavailable

CEO: Timothy Robert Danker

Sector: Financial Services

Industry: Insurance - Brokers

IPO Date: 2020-05-21

Website: https://www.selectquote.com

SelectQuote, Inc. (SLQT) - Company Information

Market Cap: 146.32M · Sector: Financial Services

SelectQuote, Inc. operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance policies to consumers from various insurance carriers in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related policies, including prescription drugs, dental, vision, and hearing plans; term life policies; and non-commercial auto and home property, and casualty policies. The company was incorporated in 1999 and is headquartered in Overland Park, Kansas.

Analyst Sentiment

62%
Buy

Based on 11 ratings

Analyst 1Y Forecast: $4.00

Average target (based on 2 sources)

Consensus Price Target

Low

$3

Median

$4

High

$5

Average

$4

Potential Upside: 381.9%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 SELECTQUOTE INC (SLQT) — Investment Overview

🧩 Business Model Overview

SELECTQUOTE INC acts as an insurance “quote-to-purchase” distributor. The value chain begins with consumer demand—primarily generated through digital marketing and other lead-generation channels—followed by a guided quote process supported by a network of licensed insurance professionals. The company then matches customers to appropriate insurance carriers and policy options, earning commission-based consideration when coverage is sold or renewed. Over time, the business model can create stickiness through repeat life events (e.g., Medicare enrollment cycles, life event-driven insurance changes) and through the operational integration of lead handling, eligibility workflows, and customer servicing.

In practice, the company monetizes insurance shopping by converting traffic and inquiries into carrier-submitted applications, supported by internal operations that manage intake, compliance checks, and customer support through the sales funnel. This structure positions SELECTQUOTE as a scalable intermediary between consumers and insurers.

💰 Revenue Streams & Monetisation Model

Revenue is predominantly commission-based, tied to insurance policies written and, in some cases, ongoing servicing or renewal economics depending on product and carrier arrangements. The model typically includes:

  • Transactional commission revenue from new policy placements (e.g., Medicare, life, and other lines).
  • Recurring-like economics where commission structures and renewal timing create repeat monetisation characteristics, though the underlying cash flows remain sensitive to customer retention and carrier terms.
  • Operational efficiency as a margin driver, because incremental demand can scale through the quote funnel if agent productivity and lead conversion remain stable.

Margin performance generally hinges on (1) conversion rate from lead to application, (2) average commission economics per product, and (3) customer acquisition cost and servicing costs per active policy. Over the cycle, underwriting risk is primarily borne by carriers, while SELECTQUOTE’s economics are more closely linked to distribution effectiveness and carrier relationships.

🧠 Competitive Advantages & Market Positioning

The company’s moat is best characterized as a combination of switching-cost dynamics and data/operational learning effects rather than a hard network-effect. While consumers may not “switch” insurance distributors frequently, they do experience repeated life-event-driven shopping where familiarity with a trusted provider and frictionless quote intake matter. For the business, the more defensible advantage tends to come from:

  • Switching costs for the distribution workflow (operational stickiness): The quote funnel, compliance tooling, and customer servicing processes create practical inertia. Competitors can attract leads, but replicating the same conversion and operational efficiency typically takes time and cost.
  • Cost advantages through funnel optimization: As lead-to-bind conversion improves and agent productivity rises, the company can spread fixed operational costs across higher throughput, improving unit economics.
  • Carrier and product integration: Established relationships and process familiarity with carrier underwriting and eligibility requirements can reduce friction in placement timelines and improve throughput.

A competitor can enter lead generation, but displacing an established distributor at scale typically requires both marketing spend and operational execution to match conversion and compliance performance. That makes share gains achievable, yet sustained leadership depends on distribution efficiency and relationship management.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, growth is supported by structural demand and the company’s ability to scale distribution economics. Key drivers include:

  • Demographic tailwinds in Medicare: Ongoing aging of the population expands the addressable base for Medicare-related shopping and plan selection.
  • Underpenetrated insurance needs: Many consumers face gaps in coverage and struggle with plan complexity, creating recurring demand for guided comparison.
  • Digital distribution maturation: Continued improvements in targeting, funnel conversion, and customer servicing can increase the effectiveness of marketing spend and raise incremental profitability.
  • Product expansion and cross-sell potential: The platform can potentially broaden engagement across lines where consumers shop during discrete life events, creating a larger wallet share per customer relationship.

The central question for multi-year outcomes is not only top-line growth, but whether conversion rates and unit economics improve or remain resilient as marketing costs, carrier terms, and regulatory expectations evolve.

⚠ Risk Factors to Monitor

  • Regulatory and compliance exposure: Insurance marketing, lead-generation practices, data usage, and agent/broker standards can face heightened scrutiny, impacting operating costs and permissible practices.
  • Carrier relationship concentration and commission pressure: Changes in carrier contracting, commission structures, or underwriting/eligibility requirements can compress margins.
  • Customer acquisition cost (CAC) volatility: Digital advertising and lead costs can rise, challenging unit economics if conversion does not improve.
  • Technological and consumer-experience disruption: Insurers or aggregators using direct-to-consumer tools can reduce intermediated demand if they offer comparable guidance at lower cost or with simpler onboarding.
  • Operational execution risk: A mismatch between demand volumes and agent capacity, compliance staffing, or fulfillment workflows can degrade conversion quality.

📊 Valuation & Market View

Market participants often value insurance distributors and lead-generation platforms using revenue-based multiples (such as EV/Sales) alongside profitability and cash-flow quality metrics (e.g., EV/EBITDA where meaningful margins exist). The valuation “needle movers” typically include:

  • Sustainable growth in policy placements rather than lead volume alone.
  • Unit economics durability: improvement or stability in conversion rate, commission mix, and cost per placed policy.
  • Operating leverage: evidence that growth translates into margin expansion through funnel efficiency.
  • Balance-sheet and cash conversion strength: working capital dynamics and the ability to fund marketing and operating needs without disproportionate dilution or leverage.

Because the business is distribution-led, the market tends to discount scenarios where unit economics deteriorate due to CAC inflation, commission headwinds, or reduced conversion quality.

🔍 Investment Takeaway

SELECTQUOTE INC fits the profile of a distribution platform where the most durable advantages come from operational efficiency, compliance-capable quote workflows, and the ability to convert marketing reach into policy placements with acceptable unit economics. The investment thesis is strongest when the company demonstrates sustained funnel conversion, resilient carrier contracting economics, and credible operating leverage—underpinned by ongoing demographic and insurance-need tailwinds.


⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

Management delivered strong Q2 operating metrics (consolidated revenue +12% to $537M; senior EBITDA margin 39%; SelectRx revenue +26% to $231M and 113k members), and repeatedly emphasized resilience via retention (north of 90%) and a 33% recapture rate. However, the call’s actionable takeaway is the FY2026 guidance reset: ~$40M aggregate EBITDA headwind ($20M PBM reimbursement + ~$20M reduced carrier marketing spend), driving consolidated revenue guidance to $1.61B–$1.71B and adjusted EBITDA to $90M–$100M. The tone is confident on long-term targets (senior 20%+ EBITDA; SelectRx exit run-rate $40M–$50M), but the Q&A shows analyst focus on near-term visibility: how the new PBM multiyear arrangement re-stabilizes reimbursement economics, whether other carriers might follow the marketing cut, and how CMS April final rates could affect MA pricing. Overall: performance strong, but near-term numbers were pressured by partner-driven economics.

AI IconGrowth Catalysts

  • Medicare Advantage AEP execution: policy volume growth of 4% vs expectations
  • Near-record senior EBITDA margin of 39% (4th consecutive AEP season with senior EBITDA margin above 30%)
  • SelectRx health care services growth: members +17% YoY to 113,000 and revenue +26% YoY to $231M
  • SelectRx clinical operating outcomes: ~20% reduction in beneficiary hospital days driven by improved medication adherence

Business Development

  • Multiyear agreement with a “large PBM” partner (announced in mid-January per remarks) to improve visibility into drug reimbursement pricing
  • New $415 million credit facility closed mid-January; extends debt maturities to 2031
  • Carrier action (national carrier) cut strategic marketing budget across all distribution channels (including SelectQuote)

AI IconFinancial Highlights

  • Consolidated revenue: +12% YoY to $537M
  • Senior revenue: $262M (+2% YoY) on increased approved policy volumes
  • Senior adjusted EBITDA: $102M (in line with last year’s strong season)
  • Senior agent retention: “north of 90%”; tenured agent mix lower due to additional hiring, but productivity per agent +12% vs two years ago
  • Marketing cost per approved policy: $326 (in line with last year; 20% lower vs 02/2024)
  • Near-record senior EBITDA margins of 39% offset temporary EBITDA pressure from PBM reimbursement headwind in healthcare services
  • Fiscal 2026 guidance cuts: consolidated revenue range revised to $1.61B–$1.71B; adjusted EBITDA range revised to $90M–$100M
  • Aggregate fiscal 2026 EBITDA headwind: ~$40M total = ~$20M PBM reimbursement impact + ~$20M marketing-budget cut by one national carrier
  • CFO stated PBM headwind is “temporarily depressed” and relates to fiscal 2026 only (no recurrence beyond fiscal 2026 per prepared remarks)
  • Operating cash flow outlook: $25M–$35M for FY2026 (up >$40M at midpoint vs last year)

AI IconCapital Funding

  • Closed new $415M credit facility (mid-January)
  • Eliminates 2026 and 2027 debt maturities; extends maturities to 2031
  • Peak season liquidity increased (to support flexibility)
  • Facility can lower term facility interest rate by up to 100 basis points

AI IconStrategy & Ops

  • Market disruption response in AEP: proactive connection with policyholders; pulled forward work on high change-potential policies to anticipate coverage gaps
  • Recapture rate: 33% (higher than last year) used as key metric for re-engagement in turbulent Medicare Advantage seasons
  • Marketing optimization lever: intentional focus on owned/operated marketing channels; geographic marketing deployment as a controllable lever
  • Health care services: prioritize cash flow and profitability; expect membership to end FY2026 flat to modestly down from ~113,000 while still driving 20%+ YoY revenue growth
  • SelectRx operating mechanics: 30-day time-and-date stamp strips; pharmacist reviews/consolidates full medication profile; ~50,000 potential dosage/interaction concerns identified in 2025

AI IconMarket Outlook

  • CMS 2027 advanced rate notice received last week (discussed as coming “soft” vs utilization/care costs); management expects ongoing dialogue and hopes for improvement by final rate notice in April
  • FY2026 targets reaffirmed despite guidance cut: senior division 20%+ EBITDA margins; health care services annualized adjusted EBITDA exit rate $40M–$50M
  • FY2026 consolidated guidance updated (post headwinds): revenue $1.61B–$1.71B; adjusted EBITDA $90M–$100M

AI IconRisks & Headwinds

  • Medicare Advantage carrier marketing budget pullback: national carrier “significantly cut their strategic marketing budget” across distribution channels; FY2026 impact ~ $20M
  • PBM reimbursement headwind: ~$20M fiscal 2026 EBITDA impact (described as one-year/temporarily depressed and non-recurring beyond FY2026)
  • Regulatory/market pricing uncertainty: CMS 2027 advanced rate notice perceived as not reflecting rising utilization/care costs; final April rate notice may change but currently creates uncertainty
  • Execution risk from carrier plan disruption: ~7% of total plans in force canceled by carriers (historically below 1%); majority of remaining beneficiaries faced negative impact on at least one plan benefit on legacy plans

Sentiment: MIXED

Note: This summary was synthesized by AI from the SLQT Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (SLQT)

© 2026 Stock Market Info — SelectQuote, Inc. (SLQT) Financial Profile